Navaux is a diagnostic research company focused on the development of assays to detect and diagnose cancer at its earliest stage. Currently, our primary offerings are related to the diagnosis of prostate and the early detection of ovarian cancer. We are unique. Our tests are not merely current assays that are bundled and packaged as a novel assay, but rather, our tests were researched and developed through The University of Arkansas for Medical Sciences Bio-Ventures Program. We cloned, developed and patented our assays for use in many forms of cancer. Our tests provide significant insight for the physician regarding the actual tumor activity rather than simply reflecting tumor burden.
Detailed Information
Fields marked — are added by the business owner once they claim this listing.